Abstract 19599: Continuous versus 3 Weeks Intermittent ECG Monitoring for Detection of Subclinical Atrial Fibrillation in High-Risk Patients

BackgroundAtrial fibrillation (AF) often occurs in a subclinical form, which makes it difficult to detect. The effect of continuous versus intermittent rhythm monitoring to detect subclinical AF is poorly investigated in patients with age ≥ 65 years, hypertension (HTN) and diabetes mellitus (DM). Th...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 134; no. Suppl_1 Suppl 1; p. A19599
Main Authors Philippsen, Tine J, Christensen, Lene S, Hansen, Michael G, Brandes, Axel
Format Journal Article
LanguageEnglish
Published by the American College of Cardiology Foundation and the American Heart Association, Inc 11.11.2016
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundAtrial fibrillation (AF) often occurs in a subclinical form, which makes it difficult to detect. The effect of continuous versus intermittent rhythm monitoring to detect subclinical AF is poorly investigated in patients with age ≥ 65 years, hypertension (HTN) and diabetes mellitus (DM). This group of patients has increased risk of developing AF and in addition a high thromboembolic risk, if AF is present.PurposeTo investigate whether continuous monitoring using an implantable loop recorder (ILR) detects more episodes of subclinical AF than daily intermittent monitoring for 3 weeks in high-risk patients.MethodsA total of 82 outpatients ≥ 65 years (median age 71.3 years (IQR 67.4-75.1)) with DM and HTN, and no history of AF or any other cardiovascular disease, were consecutively included. All patients received an ILR and were followed for a median of 342 days (IQR 208-456). To compare continuous monitoring with intermittent monitoring, we used the device to simulate a 2 minutes daily handheld ECG data collection for 3 weeks starting one month after ILR insertion. The primary end-point was AF with a minimum duration of two minutes. Oral anticoagulation (OAC) treatment was initiated upon an AF episode lasting ≥ 6 minutes.ResultsDuring follow-up 17 patients (20.7 %) were found to have subclinical AF detected by the ILR with a median time to first detected episode of 126 days (IQR 56-260) from inclusion. Thirteen patients (15.9 %) had AF ≥ 6 minutes and initiated OAC treatment. On the contrary, only 2 patients (2.4 %) also presented with AF episodes on the simulated 3 weeks intermittent monitoring (p=0.04). All detected episodes were completely asymptomatic.ConclusionsContinuous monitoring with ILR detected significantly more AF episodes than 3 weeks daily intermittent monitoring. The incidence of subclinical AF in this group of patients was surprisingly high.
ISSN:0009-7322
1524-4539